Total buying$00 buys
ROIV
Roivant Sciences Ltd.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$7.96M3 sells
Net open-market−$7.96MBuying minus selling
Active insiders7Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 05, 2026
Open-market transaction mix · 3 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 1 | 0 | $0 | $7.32M | -$7.32M |
| Oct 2026 | 0 | 2 | 0 | $0 | $640k | -$640k |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (6)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- VE-$6.6M
- GM-$2.8M
- SM-$1.7M
- TF+$1.5M
- EB-$561.7k
ROIV transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
ROIVRoivant Sciences Ltd. | Epperly Melissa B,DIR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
ROIVRoivant Sciences Ltd. | Epperly Melissa B,DIR | S · sale10b5-1 detectedSEC filing ↗ | -$32.9kView disclosure → | |
ROIVRoivant Sciences Ltd. | Epperly Melissa B,DIR | S · sale10b5-1 detectedSEC filing ↗ | -$607kView disclosure → | |
ROIVRoivant Sciences Ltd. | Epperly Melissa B,DIR | M · exercise10b5-1 detectedSEC filing ↗ | $79.1kView disclosure → | |
ROIVRoivant Sciences Ltd. | Gline MatthewCEO | F · withholdingSEC filing ↗ | -$2.78MView disclosure → | |
ROIVRoivant Sciences Ltd. | Torti FrankPRES | F · withholdingSEC filing ↗ | $1.47MView disclosure → | |
ROIVRoivant Sciences Ltd. | Sukhatme MayukhPRES · CIO | F · withholdingSEC filing ↗ | -$1.71MView disclosure → | |
ROIVRoivant Sciences Ltd. | Venker EricPRES · IC | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
ROIVRoivant Sciences Ltd. | Venker EricPRES · IC | S · sale10b5-1 detectedSEC filing ↗ | -$7.32MView disclosure → | |
ROIVRoivant Sciences Ltd. | Venker EricPRES · IC | M · exercise10b5-1 detectedSEC filing ↗ | $770kView disclosure → | |
ROIVRoivant Sciences Ltd. | Humes JenniferCAO | F · withholdingSEC filing ↗ | -$154kView disclosure → | |
ROIVRoivant Sciences Ltd. | Pulik RichardCFO | F · withholdingSEC filing ↗ | -$84.6kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period12transactionstxns
- F · Tax withholding · dominant5 · 42%
- M · Option exercise4 · 33%
- S · Open-market sells3 · 25%
Activity by reported role
A joint filing can contribute to multiple rolesPRES5
Director4
IC3
CAO1
Chief executive officer1
Chief financial officer1
CIO1
Reported Holdings After
Separated by insider, security, and ownership type
Epperly Melissa B,Common Shares · Direct
14,954Oct 01, 2026
Venker EricCommon Shares · Direct
1,599,154Sep 30, 2026
Pulik RichardCommon Shares · Direct
269,681Sep 20, 2026
Humes JenniferCommon Shares · Direct
106,419Sep 20, 2026
Venker EricStock Option (Right to Buy) · Direct
3,644,834Sep 30, 2026
Sukhatme MayukhCommon Shares · Direct
18,583,860Sep 30, 2026
Torti FrankCommon Shares · Direct
13,495,893Sep 30, 2026
Gline MatthewCommon Shares · Direct
16,583,774Sep 30, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
Roivant Sciences Ltd. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Roivant Sciences Ltd.?
Epperly Melissa B,, Gline Matthew, Torti Frank, Sukhatme Mayukh, Venker Eric, Humes Jennifer, Pulik Richard.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Epperly Melissa B, reported a sale on Oct 01, 2026 valued at $32.9k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $7,964,861.00. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.